WebbGuideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials - Revision 2 (PDF/239.66 … WebbIMPD - This gives information on the quality of any IMP (including placebo), including summaries of information related to the quality, manufacture and control of the IMP. …
EUR-Lex - 52010XC0330(01) - EN - EUR-Lex - Europa
Webb2 mars 2024 · For the IMPD preparation, a concise high-level summary of quality, manufacture, control of the IMP, data from nonclinical studies and data from its clinical use, and the overall risk and benefit assessment … Webb17 feb. 2024 · The final EMA Guidelines (Rev. 2) on the quality requirements for pharmaceutical and biological investigational medicinal products (IMPs) have been … dundee recovery road map app
D2. Investigational Medicinal Product Dossier (IMPD)
WebbSimplified version of the IMPD-Q (not to be published). Version of the IMPD-Q (not to be published). Version of the IMPD-S and E to be published (containing IMPD-S and IMPD-E; excluding IMPD-Q). Simplied version of the IMPD-S and E to be published (containing IMPD-S and IMPD-E; excluding IMPD-Q). Cover letter for the substantial modification. WebbThe IMP dossier (IMPD) gives information related to the quality of any IMP (i.e. including reference product and placebo), manufacture and control of the IMP, and data from non … Regarding data, the IMPD can be replaced by other documentation which may be … Help to enter the CELEX number in the ‘Search by CELEX number’ box in the ‘all … Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a … How to search in this section? The left-hand side of this page gives access to several … Regarding data, the IMPD can be replaced by other documentation which may be … a) de vorm en de inhoud van het in lid 2 bedoelde verzoek [namelijk een naar … II (Teatised) EUROOPA LIIDU INSTITUTSIOONIDE, ORGANITE JA … EUR-Lex — Access to European Union law — choose your language Webb15 mars 2024 · The available stability data should be presented in a tabulated form for both the DS and the relevant IMP in the Investigational Medicinal Product Dossier (IMPD) (Ref.2a&b), the regulatory document including all the Chemistry, Manufacturing and Control information on the IMP. dundee reference library